Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications
and patients taking 5mg lost an average of 15%
Educate Your Clients: Provide clear, simple information about the weight loss programs and compounds you offer
Profile 3: Poorly Controlled or Unstable Psychiatric Illness Semaglutide and tirzepatide carry no specific psychiatric black box warning, but the FDA's Adverse Event Reporting System (FAERS) contains post-marketing reports of suicidal ideation associated with GLP-1 agents, prompting the FDA to open a signal evaluation in 2023 [7]
Were excited to see VOL.U.LIFT mentioned in Marie Claire in an article by Samantha Holender highlighting how GLP-1 skincare isnt a gimmickits a response to a real, fast-growing shift in how skin behaves on these medications. As the conversation around GLP-1-related skin changes evolves, VOL.U.LIFT stands out as a targeted solution designed to address volume loss, dehydration, wrinkles, and density concerns that many are experiencing
Phase Three: Maintenance If you reach your goal weight, the Noom Med Care Team will help you plan next steps
